These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17330406)

  • 21. Recognition of tumor blood vessel normalization as a new antiangiogenic concept.
    Hellmann K
    Nat Med; 2004 Apr; 10(4):329; author reply 329-30. PubMed ID: 15057218
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours.
    Perotti A; Sessa C; Mancuso A; Noberasco C; Cresta S; Locatelli A; Carcangiu ML; Passera K; Braghetti A; Scaramuzza D; Zanaboni F; Fasolo A; Capri G; Miani M; Peters WP; Gianni L
    Ann Oncol; 2009 Apr; 20(4):741-5. PubMed ID: 19190075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technology evaluation: ABT-510, Abbott.
    Westphal JR
    Curr Opin Mol Ther; 2004 Aug; 6(4):451-7. PubMed ID: 15468604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fishing and frogging for anti-angiogenic drugs.
    De Smet F; Carmeliet P; Autiero M
    Nat Chem Biol; 2006 May; 2(5):228-9. PubMed ID: 16619017
    [No Abstract]   [Full Text] [Related]  

  • 26. The library of p-nitrophenyl esters of oligopeptides as a model to study the anticancer drug-peptide conjugates activated during tumor angiogenesis.
    Kinas RW; Opolski A; Kolesińska B; Kamiński ZJ
    Acta Pol Pharm; 2000 Nov; 57 Suppl():36-9. PubMed ID: 11293259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumors.
    Choueiri TK
    Curr Opin Investig Drugs; 2008 Jun; 9(6):658-71. PubMed ID: 18516765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiangiogenic drugs in ovarian cancer.
    Markman M
    Expert Opin Pharmacother; 2009 Oct; 10(14):2269-77. PubMed ID: 19671017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential role of vascular targeted therapy to combat against tumor.
    Chen B; Jin H; Wu K
    Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of radiation therapy and antiangiogenic therapy.
    O'Reilly MS
    Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2008 Nov; 29(11):1853-61. PubMed ID: 18655820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cilengitide Merck.
    Smith JW
    Curr Opin Investig Drugs; 2003 Jun; 4(6):741-5. PubMed ID: 12901235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis: an organizing principle for drug discovery?
    Folkman J
    Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumoral angiogenesis: review of the literature.
    Khosravi Shahi P; Fernández Pineda I
    Cancer Invest; 2008 Feb; 26(1):104-8. PubMed ID: 18181052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
    D'Onofrio A; Gandolfi A
    Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective targeting of the tumour vasculature.
    Chan LS; Daruwalla J; Christophi C
    ANZ J Surg; 2008 Nov; 78(11):955-67. PubMed ID: 18959693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic events in patients with cancer receiving antiangiogenesis agents.
    Zangari M; Fink LM; Elice F; Zhan F; Adcock DM; Tricot GJ
    J Clin Oncol; 2009 Oct; 27(29):4865-73. PubMed ID: 19704059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor angiogenesis: cause or consequence of cancer?
    Shchors K; Evan G
    Cancer Res; 2007 Aug; 67(15):7059-61. PubMed ID: 17671171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.